The chloride cotransporter NKCC1 in the embryonic etiology and treatment of FASD

氯协同转运蛋白 NKCC1 在 FASD 胚胎病因学和治疗中的作用

基本信息

  • 批准号:
    10219940
  • 负责人:
  • 金额:
    $ 50.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-08-20 至 2024-07-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT Preventable as it is by abstinence during pregnancy, maternal ethanol consumption is a significant public health concern because a significant percentage of pregnant women drink; some even binge drink to risky levels. Consumption of ethanol during pregnancy can lead to fetal alcohol spectrum disorders (FASD), hallmarked by life- long neurobehavioral and cognitive abnormalities in the offspring. Indeed, children with history of having been exposed in utero to even moderate levels of ethanol frequently present with varying degrees of deleterious neurobehavioral and cognitive outcomes. Yet, effective targeted treatment strategies for FASD/FAS are lacking or ill defined. The overarching impetus driving this research project is that a better understanding of the cellular and molecular underpinnings of FASD-associated abnormalities is needed. To this end, we will test a novel mechanistic hypothesis that ethanol disrupts chloride homeostasis in embryonic neurons, and propose to assess the therapeutic potential of targeting chloride co-transporters in order to develop and advance strategies for the pharmacological intervention of FASD in utero. Specific Aim 1: Test the hypothesis that blocking the function of NKCC1 with its antagonist bumetanide prevents and/or rescues ethanol’s effect on chloride homoeostasis in migrating embryonic GABAergic cortical interneurons and mitigates their abnormal tangential migration due to ethanol exposure in utero. Specific Aim 2: Test the hypothesis that bumetanide treatment prevents and/or rescues the impaired mPFC- dependent behavioral flexibility and attentional capacity in young adult mice exposed in utero to ethanol. Specific Aim 3: Test the hypothesis that bumetanide treatment prevents and/or rescues the (1) altered number and/or distribution of GABAergic cortical interneurons and/or (2) abnormal GABAergic and glutamatergic neurotransmission in the mPFC of young adult mice exposed in utero to ethanol. Our previous work established that GABA promotes the tangential migration of GABAergic cortical interneurons, and that ethanol affects this process to result in an “interneuronopathy” with enduring adverse consequences on cortical form, synaptic function and neurobehavior. However, the mechanism underlying this interneuronopathy is not known. The three specific aims will fill this knowledge gap and, in so doing, advance our understanding of the etiology underlying FASD. Overall, for the first time, NKCC1 will be investigated as a key unifying mechanism underlying the untoward effects of ethanol exposure in utero on tangential migration, chloride homeostasis and long- term neurobehavioral and cognitive outcomes, and pharmacologically targeted as potential therapy for FASD. In this light, this proposal addresses pressing questions in FASD that are highly significant, taking a multi-level neuroanatomical, electrophysiological and behavioral approach that is innovative, impactful, with great potential for shedding light on the therapeutic management of FASD.
摘要 虽然怀孕期间禁欲是可以接受的,但母亲的乙醇消费是一个重要的公共健康问题。 这是一个令人担忧的问题,因为相当比例的孕妇饮酒;有些人甚至狂饮到危险水平。 怀孕期间摄入乙醇会导致胎儿酒精谱系障碍(FASD),其特征是生命- 后代长期神经行为和认知异常。事实上,那些有过 在子宫内暴露于甚至中等水平的乙醇中, 神经行为和认知结果。然而,FASD/FAS缺乏有效的靶向治疗策略或存在缺陷。 定义了推动这项研究项目的首要动力是更好地了解细胞和 需要FASD相关异常的分子基础。为此,我们将测试一种新的机械 乙醇破坏胚胎神经元中氯稳态的假设,并提出评估治疗 靶向氯共转运蛋白的潜力,以开发和推进药理学 子宫内FASD的干预。 具体目的1:检验用其拮抗剂布美他尼阻断NKCC 1的功能可预防 和/或挽救乙醇对迁移的胚胎GABA能皮层中间神经元中氯稳态的作用 并减轻它们由于子宫内乙醇暴露而引起的异常切向迁移。 具体目标2:检验布美他尼治疗预防和/或挽救受损mPFC的假设。 在子宫内暴露于乙醇的年轻成年小鼠的依赖性行为灵活性和注意力能力。 具体目标3:检验布美他尼治疗预防和/或挽救(1)改变的数量 和/或GABA能皮质中间神经元的分布和/或(2)异常的GABA能和谷氨酸能 在子宫内暴露于乙醇的年轻成年小鼠的mPFC中的神经传递。 我们先前的工作证实GABA促进GABA能皮层中间神经元的切向迁移, 并且乙醇会影响这一过程,导致“神经元间病变”, 皮质形式、突触功能和神经行为。然而,这种神经间病变的机制是 不知道。这三个具体目标将填补这一知识空白,并在这样做的过程中,促进我们对 FASD的病因学。总体而言,NKCC 1将首次作为一个关键的统一机制进行调查 子宫内乙醇暴露对切线迁移、氯化物稳态和长时程的不利影响, 长期神经行为和认知结果,以及作为FASD潜在治疗的靶向治疗。在这 轻,这一建议解决了紧迫的问题,在FASD是非常重要的,采取多层次的 神经解剖学、电生理学和行为学方法,具有创新性、影响力, 为FASD的治疗管理提供了线索。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hermes H Yeh其他文献

Hermes H Yeh的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hermes H Yeh', 18)}}的其他基金

Is prenatal alcohol exposure a risk factor for the onset and progression of AD/ADRD?
产前酒精暴露是 AD/ADRD 发病和进展的危险因素吗?
  • 批准号:
    10264085
  • 财政年份:
    2020
  • 资助金额:
    $ 50.31万
  • 项目类别:
Is prenatal alcohol exposure a risk factor for the onset and progression of AD/ADRD?
产前酒精暴露是 AD/ADRD 发病和进展的危险因素吗?
  • 批准号:
    10418793
  • 财政年份:
    2020
  • 资助金额:
    $ 50.31万
  • 项目类别:
Is prenatal alcohol exposure a risk factor for the onset and progression of AD/ADRD?
产前酒精暴露是 AD/ADRD 发病和进展的危险因素吗?
  • 批准号:
    10622587
  • 财政年份:
    2020
  • 资助金额:
    $ 50.31万
  • 项目类别:
The chloride cotransporter NKCC1 in the embryonic etiology and treatment of FASD
氯协同转运蛋白 NKCC1 在 FASD 胚胎病因学和治疗中的作用
  • 批准号:
    9797285
  • 财政年份:
    2019
  • 资助金额:
    $ 50.31万
  • 项目类别:
The chloride cotransporter NKCC1 in the embryonic etiology and treatment of FASD
氯协同转运蛋白 NKCC1 在 FASD 胚胎病因学和治疗中的作用
  • 批准号:
    10675600
  • 财政年份:
    2019
  • 资助金额:
    $ 50.31万
  • 项目类别:
The chloride cotransporter NKCC1 in the embryonic etiology and treatment of FASD
氯协同转运蛋白 NKCC1 在 FASD 胚胎病因学和治疗中的作用
  • 批准号:
    10459318
  • 财政年份:
    2019
  • 资助金额:
    $ 50.31万
  • 项目类别:
Pharmacologically targeting the NKCC1 chloride cotransporter in utero for FASD
子宫内 NKCC1 氯化物协同转运蛋白的药理学靶向治疗 FASD
  • 批准号:
    9132153
  • 财政年份:
    2015
  • 资助金额:
    $ 50.31万
  • 项目类别:
Ethanol Exposure In Utero and Interneuronopathy in the Medial Prefrontal Cortex
子宫内乙醇暴露和内侧前额叶皮质的中间神经元病变
  • 批准号:
    8775840
  • 财政年份:
    2014
  • 资助金额:
    $ 50.31万
  • 项目类别:
Ethanol Exposure In Utero and Interneuronopathy in the Medial Prefrontal Cortex
子宫内乙醇暴露和内侧前额叶皮质的中间神经元病变
  • 批准号:
    9326880
  • 财政年份:
    2014
  • 资助金额:
    $ 50.31万
  • 项目类别:
Ethanol Exposure In Utero and Interneuronopathy in the Medial Prefrontal Cortex
子宫内乙醇暴露和内侧前额叶皮质的中间神经元病变
  • 批准号:
    9121346
  • 财政年份:
    2014
  • 资助金额:
    $ 50.31万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.31万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.31万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 50.31万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.31万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.31万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.31万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.31万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 50.31万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 50.31万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 50.31万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了